Stool DNA testing

A newly developed screening option has the potential to play an important role in bowel cancer detection.

A new DNA screening test for bowel cancer has been shown to detect more tumours than immunochemical faecal occult blood testing.


In fact, research recently published in the New England Journal of Medicine suggests the new test — which is performed on stool samples — is of similar efficacy to colonoscopy in detecting colorectal cancers.1

An advisory panel of the US Food and Drug Administration has unanimously recommended pre-market approval for the DNA test (Cologuard), from Exact Sciences Corporation.2

Although the